Medication violations and discontinuation of opioid therapy in a pediatric chronic pain clinic

被引:0
|
作者
Cappuccio, E. [1 ]
Tumin, D. [1 ]
Wrona, S. [1 ]
Smith, T. [1 ,2 ]
Veneziano, G. [1 ,2 ]
Bhalla, T. [1 ,2 ]
Tobias, J. D. [1 ,2 ]
机构
[1] Nationwide Childrens Hosp, Dept Anesthesiol & Med, Columbus, OH 43205 USA
[2] Ohio State Univ, Coll Med, Dept Anesthesiol & Pain Med, Columbus, OH 43210 USA
来源
关键词
opioids; opioid diversion; urine drug screen; CHRONIC NONCANCER PAIN; PREVALENCE; RISK; ABUSE;
D O I
10.14587/paccj.2020.1
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Introduction To better define the warning signs for possible opioid misuse or abuse that could be incorporated as a work flow screening process, we retrospectively reviewed cases where opioid therapy was discontinued due to suspected opioid misuse, abuse, and diversion in patients seen by the chronic pain service. Materials and methods After Institutional Review Board approval, a retrospective chart review was conducted to identify patients who were seen in the Comprehensive Pain Clinic at Nationwide Children's Hospital and had opioid therapy discontinued during the years 2015-2016 for reasons involving suspected or confirmed opioid misuse. Medical records were reviewed from the time of chronic pain service intake until the time opioid therapy was discontinued. Minor violations (e.g., request for early refills, missing or canceling appointments) and major violations (e.g. negative urine drug screen [UDS] for opioids) were identified. Results The pain clinic team identified 8 patients (2 male/6 female, ages 13-23 years) whose opioid discontinuation was related to documented or suspected opioid misuse. Only 2 patients had opioid misuse explicitly documented as the reason for opioid therapy discontinuation. Five of the 8 patients had minor violations documented, while 3 had major violations. Only 2 patients had repeated medication violations noted, although both patients continued opioid therapy for >1 year after multiple violations became apparent. Discussion and Conclusion While missing or canceling 2 or more appointments was the most commonly documented violation, a discrepancy on a UDS was the reason documented for discontinuation of opioid therapy in both patients overtly involved in opioid misuse.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [1] Modes of Therapy for Sleep Apnea in Chronic Pain Patients on Opioid Medication
    Wasef, Sara
    Mir, Soodaba
    Ryan, Clodagh
    Wong, Jean
    Selvanathan, Janannii
    Chung, Frances F.
    [J]. ANESTHESIA AND ANALGESIA, 2020, 130 : 910 - 911
  • [2] Changes in pain intensity after discontinuation of long-term opioid therapy for chronic noncancer pain
    McPherson, Sterling
    Smith, Crystal Lederhos
    Dobscha, Steven K.
    Morasco, Benjamin J.
    Demidenko, Michael I.
    Meath, Thomas H. A.
    Lovejoy, Travis I.
    [J]. PAIN, 2018, 159 (10) : 2097 - 2104
  • [3] Demographics, Diagnoses, Drugs, and Adjuvants in Patients on Chronic Opioid Therapy vs. Intermittent Use in a Tertiary Pediatric Chronic Pain Clinic
    Tolley, James A. A.
    Michel, Martha A. A.
    Sarmiento, Elisa J. J.
    [J]. CHILDREN-BASEL, 2023, 10 (01):
  • [4] Medication use among pediatric patients with chronic musculoskeletal pain syndromes at initial pain clinic evaluation
    Guite, Jessica W.
    Sherry, David D.
    Jarvis, Esther W.
    Lewen, Margaret O.
    Khan, Sarosh
    Kraemer, Francis Wickham
    [J]. PAIN MANAGEMENT, 2018, 8 (01) : 15 - 25
  • [5] Opioid Therapy in Chronic Pain
    Ballantyne, Jane C.
    [J]. PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA, 2015, 26 (02) : 201 - +
  • [6] Opioid therapy for chronic pain
    Ballantyne, JC
    Mao, JR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20): : 1943 - 1953
  • [7] Medication use among pediatric patients with chronic musculoskeletal pain referred for an initial multidisciplinary pain clinic evaluation
    Guite, J.
    Kraemer, F.
    Sherry, D.
    Wong, E.
    Olsen, M.
    [J]. JOURNAL OF PAIN, 2013, 14 (04): : S88 - S88
  • [8] Identifying opioid dose reductions and discontinuation among patients with chronic opioid therapy
    Hallvik, Sara E.
    Johnston, Kirbee
    Geddes, Jonah
    Leichtling, Gillian
    Korthuis, P. Todd
    Hartung, Daniel M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (03) : 395 - 399
  • [9] Opioid Therapy for Chronic Noncancer Pain
    Seehusen, Dean A.
    [J]. AMERICAN FAMILY PHYSICIAN, 2010, 82 (01) : 40 - 42
  • [10] Opioid Therapy in Acute and Chronic Pain
    Nafziger, Anne N.
    Barkin, Robert L.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (09): : 1111 - 1122